National Academies Press: OpenBook
« Previous: References
Suggested Citation:"Appendix A: Workshop Agenda." National Academies of Sciences, Engineering, and Medicine. 2017. Integration of FDA and NIOSH Processes Used to Evaluate Respiratory Protective Devices for Health Care Workers: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/23679.
×

A

Workshop Agenda

Integration of FDA and NIOSH Processes Used to Evaluate Respiratory Protective Devices for Health Care Workers: A Workshop

Keck Center of the National Academies
of Sciences, Engineering, and Medicine
500 Fifth Street, NW, Room 100
Washington, DC

August 1, 2016

Workshop Objective:

  • Ensure health care worker safety, health, and productivity by discussing potential next steps to integrate federal processes (FDA and NIOSH) used to certify and approve N95 respiratory protective devices for use in health care settings.

Starting Points:

  • All participants are familiar with the FDA and NIOSH approval and certification processes. Background materials outlining these processes have been provided to all workshop participants. The workshop will focus on potential next steps and priorities for harmonization:
    • FDA—Approval of surgical N95 respirators, which in addition to NIOSH certification also meet FDA requirements regarding flammability, fluid resistance, and biocompatibility
Suggested Citation:"Appendix A: Workshop Agenda." National Academies of Sciences, Engineering, and Medicine. 2017. Integration of FDA and NIOSH Processes Used to Evaluate Respiratory Protective Devices for Health Care Workers: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/23679.
×
  • NIOSH—Certification of all N95 respirators with tests, including for filtration performance
7:45 – 8:30 a.m. Breakfast, Available in Keck Atrium, 3rd floor
8:30 – 8:40 a.m. Welcome and Introductions

Linda Hawes Clever, Chair, Workshop Planning Committee

8:40 – 9:00 a.m. Goals for the Workshop

Maryann D’Alessandro, National Personal Protective Technology Laboratory (NPPTL)

Aftin Ross, Food and Drug Administration (FDA)

Discussion
9:00 – 10:20 a.m. Panel 1: Perspectives from Users, Manufacturers, and Distributors

Facilitator: Barbara DeBaun

9:00 – 9:05 Panel Introductions
9:05 – 9:55 Presentations
  • Jeffrey Nesbitt, Mayo Clinic
  • Geeta Sood, Johns Hopkins University
  • James Chang, University of Maryland Medical Center
  • Craig Colton, 3M
  • Akhil Agrawal, American Medical Depot

9:55 – 10:20 Discussion

Issues for Presentations and Discussion:
  • What N95 respirator attributes need to be tested to assure worker safety and health in health care settings (e.g., filtration, flammability, fluid resistance, biocompatibility, others)?
Suggested Citation:"Appendix A: Workshop Agenda." National Academies of Sciences, Engineering, and Medicine. 2017. Integration of FDA and NIOSH Processes Used to Evaluate Respiratory Protective Devices for Health Care Workers: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/23679.
×
  • What, if any, are the current issues being faced with having two types of N95 respirators (surgical N95s and standard N95s)?
  • In your opinion, what are the priorities for research, testing, and post-market surveillance to improve N95s for health care workers’ safety and health? What are the priorities to be considered in the integration of FDA and NIOSH evaluation processes for N95s?
10:20 – 10:30 a.m. BREAK
10:30 a.m. – 12:00 p.m. Panel 2: State of the Science and Priorities for Research and Standards DevelopmentFiltration Performance and Fluid Resistance
Facilitator: Jim Johnson

10:30 – 10:35 Panel Introductions

10:35 – 11:35 Presentations

10:35 – 11:05 Filtration Performance

  • Robert Eninger, Air Force Institute of Technology
  • Sergey Grinshpun, University of Cincinnati

11:05 – 11:35 Fluid Resistance

  • Brandon Williams, Nelson Laboratories
  • Steven Elliott, FDA

11:35 – 12:00 Discussion

Issues for Presentations and Discussion:
  • What improvements are needed to the tests and test methods? What efforts are under way to revise the standards?
  • What are the research gaps and priorities?
  • What are the priorities for research, test method development and refinement, and
Suggested Citation:"Appendix A: Workshop Agenda." National Academies of Sciences, Engineering, and Medicine. 2017. Integration of FDA and NIOSH Processes Used to Evaluate Respiratory Protective Devices for Health Care Workers: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/23679.
×

post-market surveillance of N95s to improve health care workers’ safety and health? What are the priorities to be considered in integrating FDA and NIOSH evaluation processes for N95s used in health care settings?

12:00 – 12:45 p.m. Lunch, Available in Keck Atrium, 3rd floor
12:45 – 2:00 p.m. Panel 3: State of the Science and Priorities for Research and Standards DevelopmentFlammability and Biocompatibility/Usability
Facilitator: Mark Shirley

12:45 – 12:50 Panel Introductions

12:50 – 1:35 Presentations

12:50 – 1:20 Flammability

  • Samy Rengasamy, NPPTL
  • Roger Barker, North Carolina State University

1:20 – 1:35 Biocompatibility/Usability

  • BiFeng Qian, FDA

1:35 – 2:00 Discussion

Issues for Presentations and Discussion:
  • What improvements are needed to the tests and test methods? What efforts are under way to revise the standards?
  • What are the research gaps and priorities?
  • What are the priorities for research, test method development and refinement, and post-market surveillance of N95s to improve health care workers safety and health? What are the priorities to be considered in integrating FDA and NIOSH evaluation processes for N95s used in health care settings?
Suggested Citation:"Appendix A: Workshop Agenda." National Academies of Sciences, Engineering, and Medicine. 2017. Integration of FDA and NIOSH Processes Used to Evaluate Respiratory Protective Devices for Health Care Workers: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/23679.
×
2:00 – 2:45 p.m. Panel 4: Options for Post-Market Surveillance
Facilitator: Dan Shipp

2:00 – 2:05 Panel Introductions

2:05 – 2:20 Presentation

  • Jeffrey Peterson and James Harris, NPPTL

2:20 – 2:45 Discussion

Issues for Presentations and Discussion:
  • Overview of current processes for post-market surveillance of N95 respirators and other similar types of devices
  • Examples from other devices/processes
  • What are suggested considerations for improving post-market surveillance?
2:45 – 3:00 p.m. Break and Move to Breakout Sessions
3:00 – 4:15 p.m. Breakout Sessions
Breakout #1Next Steps in Research for Improving Test Methods (Room 100)
Facilitator: Howard Cohen
Tasks for the breakout group:
  • Identify research gaps for test methods used to evaluate N95 respirators for use by health care workers
  • Identify three to five research priorities
  • Outline next steps for filling the research gaps
Breakout #2Issues in Improving and Streamlining the Integration of FDA and NIOSH Processes for N95s Used in Health Care Settings (Room 103)
Facilitator: Kerri Rupe
Suggested Citation:"Appendix A: Workshop Agenda." National Academies of Sciences, Engineering, and Medicine. 2017. Integration of FDA and NIOSH Processes Used to Evaluate Respiratory Protective Devices for Health Care Workers: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/23679.
×
Tasks for the breakout group:
  • Identify outstanding issues in the integration of the FDA and NIOSH processes
  • Discuss the strengths and weaknesses of various approaches to testing (i.e., third-party testing, government lab testing, manufacturer attestation of testing) as relevant to N95s used in health care settings
  • Identify priorities and delineate potential next steps for completing the integration of the evaluation processes
Breakout #3Priorities for Health Care Workers (Room 106)
Facilitator: Cecile Rose
Tasks for the breakout group:
  • Discuss whether the attributes needed for respiratory protection for health care workers differ from the attributes needed for respiratory protection for other workers (e.g., agriculture, industry)
  • Identify priorities for improving N95s for use by health care workers
4:15 – 4:30 p.m. Break and Move to Plenary Session
4:30 – 5:30 p.m. Plenary Session, Keck 100
Facilitator: Linda Hawes Clever
Reports on Potential Next Steps and Priorities
Public Comments
Closing Remarks
5:30 p.m. ADJOURN
Suggested Citation:"Appendix A: Workshop Agenda." National Academies of Sciences, Engineering, and Medicine. 2017. Integration of FDA and NIOSH Processes Used to Evaluate Respiratory Protective Devices for Health Care Workers: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/23679.
×
Page 51
Suggested Citation:"Appendix A: Workshop Agenda." National Academies of Sciences, Engineering, and Medicine. 2017. Integration of FDA and NIOSH Processes Used to Evaluate Respiratory Protective Devices for Health Care Workers: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/23679.
×
Page 52
Suggested Citation:"Appendix A: Workshop Agenda." National Academies of Sciences, Engineering, and Medicine. 2017. Integration of FDA and NIOSH Processes Used to Evaluate Respiratory Protective Devices for Health Care Workers: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/23679.
×
Page 53
Suggested Citation:"Appendix A: Workshop Agenda." National Academies of Sciences, Engineering, and Medicine. 2017. Integration of FDA and NIOSH Processes Used to Evaluate Respiratory Protective Devices for Health Care Workers: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/23679.
×
Page 54
Suggested Citation:"Appendix A: Workshop Agenda." National Academies of Sciences, Engineering, and Medicine. 2017. Integration of FDA and NIOSH Processes Used to Evaluate Respiratory Protective Devices for Health Care Workers: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/23679.
×
Page 55
Suggested Citation:"Appendix A: Workshop Agenda." National Academies of Sciences, Engineering, and Medicine. 2017. Integration of FDA and NIOSH Processes Used to Evaluate Respiratory Protective Devices for Health Care Workers: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/23679.
×
Page 56
Next: Appendix B: Workshop Participants »
Integration of FDA and NIOSH Processes Used to Evaluate Respiratory Protective Devices for Health Care Workers: Proceedings of a Workshop Get This Book
×
Buy Paperback | $40.00 Buy Ebook | $32.99
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

Both the Food and Drug Administration (FDA) and the National Institute for Occupational Safety and Health (NIOSH) have responsibilities for evaluating and regulating respiratory protective devices (“respirators”) for health care workers. Respirators protect the user from respiratory hazards by either removing contaminants from the air (air-purifying respirators) or by supplying clean air from another source (air-supplying respirators). Respirators that are used in workplaces in the United States must be approved by NIOSH and meet standards and test results specified by regulation.

Respirators used by health care workers are air-purifying respirators that generally fall into three types: (1) disposable particulate filtering facepiece respirators (also termed N95s); (2) elastomeric respirators, also known as reusable respirators because they use a replaceable filter; or (3) powered air-purifying air respirators.

To provide input to NIOSH and FDA and to discuss potential next steps to integrate the two agencies’ processes to certify and approve N95 respirators for use in health care settings, a workshop was held by the National Academies of Sciences, Engineering, and Medicine in August 2016. The workshop was focused on exploring the strengths and limitations of several current test methods for N95 respirators as well as identifying ongoing research and research needs. This publication summarizes the presentations and discussions from the workshop.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!